256 related articles for article (PubMed ID: 26954073)
21. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
[TBL] [Abstract][Full Text] [Related]
22. Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis.
Motawi TK; Rizk SM; Ibrahim TM; Ibrahim IA
Cell Biochem Funct; 2016 Apr; 34(3):142-8. PubMed ID: 26916216
[TBL] [Abstract][Full Text] [Related]
23. The diagnostic value of urine-based survivin mRNA test using reverse transcription-polymerase chain reaction for bladder cancer: a systematic review.
Xia Y; Liu YL; Yang KH; Chen W
Chin J Cancer; 2010 Apr; 29(4):441-6. PubMed ID: 20346223
[TBL] [Abstract][Full Text] [Related]
24. MicroRNAs as novel biomarkers in the diagnosis of non-small cell lung cancer: a meta-analysis based on 20 studies.
Chen L; Jin H
Tumour Biol; 2014 Sep; 35(9):9119-29. PubMed ID: 25027397
[TBL] [Abstract][Full Text] [Related]
25. Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer.
Tölle A; Jung M; Rabenhorst S; Kilic E; Jung K; Weikert S
Oncol Rep; 2013 Oct; 30(4):1949-56. PubMed ID: 23877086
[TBL] [Abstract][Full Text] [Related]
26. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
27. Urine microRNAs as biomarkers for bladder cancer: a diagnostic meta-analysis.
Cheng Y; Deng X; Yang X; Li P; Zhang X; Li P; Tao J; Lu Q; Wang Z
Onco Targets Ther; 2015; 8():2089-96. PubMed ID: 26316777
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs as novel biomarkers for the differentiation of malignant versus benign thyroid lesions: a meta-analysis.
Zhou GJ; Xiao M; Zhao LN; Tang JG; Zhang L
Genet Mol Res; 2015 Jul; 14(3):7279-89. PubMed ID: 26214406
[TBL] [Abstract][Full Text] [Related]
29. Identification of microRNAs as novel biomarkers for glioma detection: a meta-analysis based on 11 articles.
Qu S; Guan J; Liu Y
J Neurol Sci; 2015 Jan; 348(1-2):181-7. PubMed ID: 25510379
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of circulating microRNAs as biomarkers for breast cancer: a meta-analysis study.
Cui Z; Lin D; Song W; Chen M; Li D
Tumour Biol; 2015 Feb; 36(2):829-39. PubMed ID: 25296735
[TBL] [Abstract][Full Text] [Related]
31. Clinical use of microRNAs as potential non-invasive biomarkers for detecting non-small cell lung cancer: a meta-analysis.
Wang H; Wu S; Zhao L; Zhao J; Liu J; Wang Z
Respirology; 2015 Jan; 20(1):56-65. PubMed ID: 25440223
[TBL] [Abstract][Full Text] [Related]
32. Cell-free microRNAs as non-invasive biomarkers in glioma: a diagnostic meta-analysis.
Wang J; Che F; Zhang J
Int J Biol Markers; 2019 Sep; 34(3):232-242. PubMed ID: 30968749
[TBL] [Abstract][Full Text] [Related]
33. Blood-Based Circulating MicroRNAs are Potential Diagnostic Biomarkers for Leukemia: Result from a Meta-Analysis.
Xu LH; Guo Y; Zhang XL; Chen JJ; Hu SY
Cell Physiol Biochem; 2016; 38(3):939-49. PubMed ID: 26938054
[TBL] [Abstract][Full Text] [Related]
34. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.
Wu K; Li L; Li S
Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of urinary microRNAs as non-invasive biomarkers for bladder cancer: a meta-analysis.
Ding M; Li Y; Wang H; Lv Y; Liang J; Wang J; Li C
Int J Clin Exp Med; 2015; 8(9):15432-40. PubMed ID: 26629032
[TBL] [Abstract][Full Text] [Related]
36. MicroRNAs as a potential tool in the differential diagnosis of thyroid cancer: a systematic review and meta-analysis.
Wei WJ; Shen CT; Song HJ; Qiu ZL; Luo QY
Clin Endocrinol (Oxf); 2016 Jan; 84(1):127-33. PubMed ID: 25510178
[TBL] [Abstract][Full Text] [Related]
37. Analysis of circulating microRNA biomarkers for breast cancer detection: a meta-analysis.
Liu L; Wang S; Cao X; Liu J
Tumour Biol; 2014 Dec; 35(12):12245-53. PubMed ID: 25195131
[TBL] [Abstract][Full Text] [Related]
38. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.
Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S
Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545
[TBL] [Abstract][Full Text] [Related]
39. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
[TBL] [Abstract][Full Text] [Related]
40. Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer.
Du M; Shi D; Yuan L; Li P; Chu H; Qin C; Yin C; Zhang Z; Wang M
Sci Rep; 2015 May; 5():10437. PubMed ID: 26014226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
